Earnings U.S. NYSE Nasdaq 100 Tech Politics AI Science SEC Bitcoin (BTC) Donald Trump Business Wall Street Energy Markets Investing Dow Jones Dividend NVIDIA (NVDA) World Dogecoin (DOGE) S&P 500 Hedge Funds Economy Money Elon Musk China Fed Crude Oil Gary Gensler Inflation Tesla (TSLA) U.K. Gold Software Meta Platforms (META) Entertainment Apple (AAPL) Retail Amazon (AMZN) Ripple (XRP) Health Taxes Blockchain Dell (DELL) Live Wealth Ethereum (ETH) Options Sports Europe Retirement Real Estate Canada Natural Gas Security Microsoft (MSFT) Current 3M (MMM) Finance Internet Tax Jim Cramer OpenAI ChatGPT Truist Financial Corp (TFC) Boeing (BA) Google Insurance MicroStrategy Solana (SOL) Holidays Manufacturing Cars Warren Buffett War Pharmaceuticals Costco (COST) Ukraine Airlines Environment Economics Mining Japan Interest Rates Goldman Sachs (GS) Silver York Construction New York Walmart (WMT) BlackRock (BLK) South Korea Space Stellar (XLM) Crash Stablecoins Mortgage Intel (INTC) REITsMore +
Stock Market News Stock Market News
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Cryptocurrency
  • Forex
  • Tech
  • Politics
  • +

5 hours Amgen stock sinks as weightloss drug fails to impressFXStreet

Amgen (AMGN) stock is losing weight on Tuesday after its weightloss drug left more questions than answers.

Amgen (AMGN)

  X     

2 hours Final Trade: JWN, IWM, GCO, AMGNYouTube   X     

2 hours Wait for longer-term data with Amgen’s GLP-1, says Piper Sandler’s Christopher RaymondYouTube   X     

6 hours Amgen: MariTide Underwhelms, But There Are Ways To WinSeeking Alpha   X     

8 hours Chart of the Day: AmgenYouTube   X     

11 hours Cramer’s Stop Trading: AmgenYouTube   X     

11 hours Amgen Stock Dives After Weight-Loss Drug Data. Here’s What to Know.Yahoo Finance   X     

12 hours Amgen Crashes 9% Despite ‘Truly Remarkable’ Results For Obesity TreatmentInvestor's Business Daily   X     

12 hours Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know.Yahoo Finance   X     

13 hours Amgen says obesity drug caused up to 20% weight loss after a year, with no plateauYouTube   X     

16 hours These Stocks Are Moving the Most Today: GM, Ford, Amgen, Eli Lilly, Super Micro, Best Buy, Analog Devices, Kohl’s, Semtech, and MoreYahoo Finance   X     

4 days Why Amgen (AMGN) is a Top Value Stock for the Long-TermZacks   X     

1 week Amgen Sells Off: Keep Calm And Buy The DipSeeking Alpha   X     

1 week Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on ItZacks   X     

2 weeks 2 Reasons to Buy Amgen Stock, and 1 Reason to Be CautiousThe Motley Fool   X     

2 weeks Amgen, Merck stocks dive as Trump picks anti-vaxxer RFK Jr. to lead US healthcareFXStreet   X     

2 weeks Amgen Shrugs Off Bone Density Concerns Related to Obesity CandidateZacks   X     

2 weeks Amgen Inc. (AMGN) UBS Global Healthcare Conference (Transcript)Seeking Alpha   X     

2 weeks Trade Tracker: Joe Terranova sells Amgen and buys XBIYouTube   X     

2 weeks Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?Investor's Business Daily   X     

2 weeks Amgen dismisses bone density concerns related to its new weight-loss drugInvesting.com   X     

2 weeks Amgen sinks as Cantor flags issues with obesity drugYouTube   X     

2 weeks Amgen stock falls as analysts mull over weight loss drug’s bone density dataCNBC   X     

2 weeks Amgen Drops 7% After A ‘Big Unknown Risk’ Rattles Its Monthly Obesity ShotInvestor's Business Daily   X     

3 weeks Big Pharma’s Obesity Bonanza Faces New TestsThe Wall Street Journal   X     

3 weeks Amgen: A Biotech Giant Offering Value And Growth In A Frothy MarketSeeking Alpha   X     

4 weeks Analyst Report: AMGEN Inc.Yahoo Finance   X     

4 weeks Market Digest: AAPL, AMGN, AMP, BBY, CTSH, EPD, MCO, UNP, MA, VRSK, PPC, GEHCYahoo Finance   X     

4 weeks Amgen Inc. (AMGN) Q3 2024 Earnings Call TranscriptSeeking Alpha   X     

4 weeks Amgen Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha   X     

4 weeks Amgen (AMGN) Q3 2024 Earnings Call TranscriptThe Motley Fool   X     

4 weeks Amgen ‘Laser-Focused’ On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFOInvestor's Business Daily   X     

4 weeks Amgen beats Q3 earnings estimates, raises full-year guidanceInvesting.com   X     

4 weeks Pfizer Unveils Its Next Black Box In Obesity. It’s Taking On Amgen.Investor's Business Daily   X     

4 weeks First American Bank Has $4.18 Million Stake in Amgen Inc. (NASDAQ:AMGN)MarketBeat   X     

4 weeks Zacks Research Forecasts Amgen’s Q1 Earnings (NASDAQ:AMGN)MarketBeat   X     

1 month Amgen Inc. Declares Quarterly Dividend of $2.25 (NASDAQ:AMGN)MarketBeat   X     

1 month Amgen Q3 Earnings Review: So Many Questions, But MariTide Data Top Of The ListSeeking Alpha   X     

1 month Amgen Gears Up to Report Q3 Earnings: Here’s What to ExpectZacks   X     

1 month Allspring Global Investments Holdings LLC Sells 11,091 Shares of Amgen Inc. (NASDAQ:AMGN)MarketBeat   X     

1 month Amgen (NASDAQ:AMGN) Stock Rating Reaffirmed by Cantor FitzgeraldMarketBeat   X     

1 month Amgen Inc. (NASDAQ:AMGN) Shares Sold by Raleigh Capital Management Inc.MarketBeat   X     

1 month Why Amgen (AMGN) Dipped More Than Broader Market TodayZacks   X     

1 month Amgen (NASDAQ:AMGN) Price Target Raised to $383.00MarketBeat   X     

1 month Penn Davis Mcfarland Inc. Raises Stake in Amgen Inc. (NASDAQ:AMGN)MarketBeat   X     

1 month Creative Planning Has $63.40 Million Stock Position in Amgen Inc. (NASDAQ:AMGN)MarketBeat   X     

1 month Raymond James & Associates Sells 71,201 Shares of Amgen Inc. (NASDAQ:AMGN)MarketBeat   X     

More news +
Home | Contact
  • X

© 2024 The Stock Market News